How stress can mask the symptoms of chronic disease
UC expert featured in New York Times article
Ongoing research has found stress is closely linked with many chronic diseases including asthma, heart disease, arthritis, lupus and inflammatory bowel disease. At the same time, many issues caused by stress, like headaches and blood pressure problems, can also be symptoms of chronic illnesses.
The University of Cincinnati's Charles Hattemer, MD, spoke with the New York Times on how stress can play a part in triggering chronic diseases.
Hattemer, professor, division chief of cardiovascular health and disease and Mabel Stearns Stonehill Endowed Chair in the Department of Internal Medicine in UC's College of Medicine, and a UC Health physician, said stress naturally kickstarts the fight-or-flight response.
When people are stressed for weeks or months, their bodies may be unable to maintain other functions. Hattemer said stress hormones can also chronically elevate blood pressure or increase plaque deposits, which can damage the heart over time.
Read the New York Times article.
Featured photo at top courtesy of Pixabay.
Related Stories
Phenols, found in many products, could upset heart's rhythms
October 7, 2024
Chemicals called environmental phenols include food preservatives, plastics ingredients such as BPA and the parabens in shampoos, so they are ubiquitous in everyday life. Now, University of Cincinnati research suggests that higher exposure to phenols might trigger changes in the heart's electrical system and rhythms.
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
Pennsylvania news: Personalized treatment for deadly blood and bone marrow cancer
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.